DOMH
Dominari Holdings Inc.
NASDAQ · Financial Services · Financial - Capital Markets · US
$2.45
+0.41%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.48
From 52W high−66.98%
Volume332308.00
Market cap$59.40M
P/E (TTM)—
P/S (TTM)0.4x
Div yield30.31%
Key dataSep 18, 2026
Open
$2.48
From 52W high
−66.98%
Volume
332308.00
Market cap
$59.40M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.4x
P/E (TTM)
—
RSI (14)
56.4
MomentumView details →
1D Return
+0.41%
YTD Return
−49.19%
SummaryUpdated Jun 1, 2026
Dominari Holdings Inc. (NASDAQ:DOMH) is a biotechnology company founded in 1967 and headquartered in New York, New York. Originally incorporated as Aikido Pharma Inc., the company rebranded to its current name in December 2022. With a history spanning over five decades, Dominari has evolved from its early origins to focus on developing innovative small-molecule therapeutics for cancer treatment and antiviral applications. The company operates in the highly regulated and capital-intensive biotechnology sector, where drug development timelines typically span many years and require substantial investment before generating meaningful revenue.
Similar companies
Latest newsMore news →
Several Trump Organization executives returned to Cuba in recent months under the aegis of Dominari Holdings for meetings, after previously exploring real estate deals and registering the Trump trademark there in 2008.3d agoDominari Holdings Inc. announced a share repurchase program of up to $5,000,000 of its outstanding common stock.3d ago